SubscribeSign In
Viruses & InfectionsWhat to know this winter
Flu SeasonSymptomsMedicine SupplyStrepDecongestant MaskingFree TestsBoosters

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/articles/former-outcome-health-executives-found-guilty-of-fraud-912f9bb0

Former Outcome Health Executives Found Guilty of Fraud

Verdict caps fall of startup’s executive team led by Rishi Shah, who could face years in prison

Former Outcome Health CEO Rishi Shah was convicted on most of 22 criminal counts of wire, mail and bank fraud.Photo: Antonio Perez/Zuma Press
By Rolfe Winkler
, John Keilman
 and Patrick Thomas

CHICAGO—A federal jury convicted three former executives of the once-highflying startup Outcome Health on several charges that they ran a billion-dollar scheme that defrauded customers including major pharmaceutical companies such as Novo Nordisk A/S as well as investors including Goldman Sachs Group Inc.

What's News

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a subscriber? Sign In

Sponsored Offers
  • The Wall Street Journal
  • Sign In
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Podcasts
  • Snapchat
  • Google Play
  • App Store
  • Privacy Notice
  • Cookie Notice
  • Copyright Policy
  • Data Policy
  • Subscriber Agreement & Terms of Use
  • Your Ad Choices
  • Accessibility
  • Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved.
  • Google Play
  • App Store
Sign In
Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.